ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HEPA Hepion Pharmaceuticals Inc

1.41
-0.08 (-5.37%)
Last Updated: 11:06:09
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Hepion Pharmaceuticals Inc HEPA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.08 -5.37% 1.41 11:06:09
Open Price Low Price High Price Close Price Prev Close
1.52 1.37 1.54 1.49
more quote information »

Recent News

Date Time Source Heading
4/19/202416:30GLOBEHepion Pharmaceuticals Initiates Wind-Down Activities in..
2/16/202409:02EDGAR2Form 8-K - Current report
2/16/202408:00GLOBEHepion Pharmaceuticals Announces Exercise of Warrants for..
2/14/202415:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/03/202417:15GLOBEHepion Pharmaceuticals to Present at NASH-TAG 2024
1/03/202416:30EDGAR2Form 8-K - Current report
12/07/202308:00GLOBEHepion Pharmaceuticals Announces Restructuring Plan to..
11/28/202316:15GLOBEHepion Pharmaceuticals to Present at the 7th Obesity & NASH..
11/13/202316:05GLOBEHepion Pharmaceuticals Announces Major Reductions in Liver..
11/10/202308:50GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
11/09/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
10/25/202308:30GLOBEHepion Pharmaceuticals’ Rencofilstat Demonstrates..
9/29/202308:00GLOBEHepion Pharmaceuticals Announces $5.0 Million Registered..
9/21/202316:05GLOBEHepion Pharmaceuticals to Participate in 2023 Cantor Global..
9/21/202308:00GLOBENew Anti-Cancer Opportunities Revealed for Hepion..
9/19/202309:00GLOBEHepion Pharmaceuticals Discovers Novel Rencofilstat Action..
9/18/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202308:45GLOBERencofilstat Produces Positive Outcomes in Translational..
9/06/202316:40EDGAR2Form 8-K - Current report
9/06/202316:30GLOBEHepion Pharmaceuticals Announces Management Changes
7/24/202316:04EDGAR2Form 8-K - Current report
7/21/202316:41EDGAR2Form 8-K - Current report
7/21/202316:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/15/202316:45GLOBEHepion Pharmaceuticals to Present Two Posters at EASL..
6/15/202308:22GLOBEHepion Pharmaceuticals Announces Passing of Key Safety..
5/24/202316:45GLOBEHepion Pharmaceuticals to Highlight AI-POWR™ at the 2023..
5/22/202307:00GLOBEHepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial..
5/19/202316:05GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
5/10/202311:15GLOBEHepion Pharmaceuticals, Inc. Announces Reverse Stock Split

Your Recent History

Delayed Upgrade Clock